Volume 10, Issue 3 (2024)
IEM 2024, 10(3): 203-212 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tabatabaee Bafroee A S, Rabiee M H, Barani B, Poorchini P. Factors related to fecal carriage of ESBL producing Escherichia coli in drug users from southwestern Iran. IEM 2024; 10 (3) :203-212
URL: http://iem.modares.ac.ir/article-4-72567-en.html
URL: http://iem.modares.ac.ir/article-4-72567-en.html
1- East Tehran Branch, Islamic Azad University, Qiam Dasht, Tehran, Iran. Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran , a.tabatabaee@iauet.ac.ir
2- East Tehran Branch, Islamic Azad University, Qiam Dasht, Tehran, Iran. Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. Department of Epidemiology, Razi Vaccine and Serum Research Institute, AREEO, Karaj, Iran
3- East Tehran Branch, Islamic Azad University, Qiam Dasht, Tehran, Iran. Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
2- East Tehran Branch, Islamic Azad University, Qiam Dasht, Tehran, Iran. Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. Department of Epidemiology, Razi Vaccine and Serum Research Institute, AREEO, Karaj, Iran
3- East Tehran Branch, Islamic Azad University, Qiam Dasht, Tehran, Iran. Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
Abstract: (790 Views)
Background: The escalating prevalence of multidrug-resistant (MDR) commensal intestinal bacteria characterized by extended-spectrum β-lactamase (ESBL) production is an alarming global health threat. Drug users have been introduced as a major source of antibiotic-resistant bacteria, possibly due to drug abuse. The present study aimed to investigate the potential factors related to fecal carriage of MDR ESBL-producing intestinal Escherichia coli (E. coli) in drug users in the southwest of Iran.
Materials & Methods: In this cross-sectional study, stool samples of 109 drug users were collected and cultured. After the biochemical confirmation of E. coli isolates, the antimicrobial resistance pattern and ESBL production of the isolates were determined. Then logistic regression analysis was conducted to determine possible factors related to fecal carriage of MDR ESBL-producing intestinal E. coli.
Findings: Logistic regression analysis indicated that increasing age and duration of addiction were associated with increased risk of MDR ESBL-producing E. coli carriage in the intestinal flora of drug users (p< .05). Moreover, oral drug use compared to the smoking method led to a higher carriage rate of MDR ESBL-producing E. coli in the intestinal flora of drug users (p< .05). Also, self-employed drug users compared to those with fixed public occupation showed higher rates of MDR ESBL-producing E. coli carriage in their intestinal flora (p< .05).
Conclusion: Age, duration of addiction, method of drug use, and occupation were significantly associated with MDR ESBL-producing E. coli colonization.
Materials & Methods: In this cross-sectional study, stool samples of 109 drug users were collected and cultured. After the biochemical confirmation of E. coli isolates, the antimicrobial resistance pattern and ESBL production of the isolates were determined. Then logistic regression analysis was conducted to determine possible factors related to fecal carriage of MDR ESBL-producing intestinal E. coli.
Findings: Logistic regression analysis indicated that increasing age and duration of addiction were associated with increased risk of MDR ESBL-producing E. coli carriage in the intestinal flora of drug users (p< .05). Moreover, oral drug use compared to the smoking method led to a higher carriage rate of MDR ESBL-producing E. coli in the intestinal flora of drug users (p< .05). Also, self-employed drug users compared to those with fixed public occupation showed higher rates of MDR ESBL-producing E. coli carriage in their intestinal flora (p< .05).
Conclusion: Age, duration of addiction, method of drug use, and occupation were significantly associated with MDR ESBL-producing E. coli colonization.
Keywords: Drug users, Intestinal Escherichia coli, MDR, ESBLs, Risk factors, Logistic regression analysis
Article Type: Original Research |
Subject:
Bacteriology
Received: 2023/11/21 | Accepted: 2024/04/27 | Published: 2024/08/20
Received: 2023/11/21 | Accepted: 2024/04/27 | Published: 2024/08/20
References
1. Meng M, Li Y, Yao H. Plasmid-mediated transfer of antibiotic resistance genes in soil. Antibiotics. 2022;11(4):525. [DOI:10.3390/antibiotics11040525] [PMID] []
2. Sultan I, Rahman S, Jan AT, Siddiqui MT, Mondal AH, Haq QMR. Antibiotics, resistome and resistance mechanisms: A bacterial perspective. Front Microbiol. 2018;9:2066. [DOI:10.3389/fmicb.2018.02066] [PMID] []
3. Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al. The global threat of antimicrobial resistance: Science for intervention. New Microbes New Infect. 2015;6:22-9. [DOI:10.1016/j.nmni.2015.02.007] [PMID] []
4. Zhang H, Zhou Y, Guo S, Chang W. Multidrug resistance found in extended-spectrum beta-lactamase-producing Enterobacteriaceae from rural water reservoirs in Guantao, China. Front Microbiol. 2015;6:267.
https://doi.org/10.3389/fmicb.2015.00239 [DOI:10.3389/fmicb.2015.00267]
5. Barani A, Tabatabaee Bafroee AS, Jabalameli L. Abundance of extended-spectrum β-lactamase genes among intestinal Escherichia coli strains from drug users. Arch Microbiol. 2021;203(6):3245-55. [DOI:10.1007/s00203-021-02316-4] [PMID]
6. Al-Agamy MH, El-Mahdy TS, Radwan HH, Poirel L. Cooccurrence of NDM-1, ESBL, RmtC, AAC (6′)-Ib, and QnrB in clonally related Klebsiella pneumoniae isolates together with coexistence of CMY-4 and AAC (6′)-Ib in Enterobacter cloacae isolates from Saudi Arabia. Biomed Res Int. 2019;2019. [DOI:10.1155/2019/6736897] [PMID] []
7. Moghadam MT, Shariati A, Mirkalantari S, Karmostaji A. The complex genetic region conferring transferable antibiotic resistance in multidrug-resistant and extremely drug-resistant Klebsiella pneumoniae clinical isolates. New Microbes New Infect. 2020;36:100693. [DOI:10.1016/j.nmni.2020.100693] [PMID] []
8. Fadare FT, Okoh AI. Distribution and molecular characterization of ESBL, pAmpC β-lactamases, and non-β-lactam encoding genes in Enterobacteriaceae isolated from hospital wastewater in Eastern Cape province, South Africa. PloS One. 2021;16(7):e0254753. [DOI:10.1371/journal.pone.0254753] [PMID] []
9. Athanasakopoulou Z, Reinicke M, Diezel C, Sofia M, Chatzopoulos DC, Braun SD, et al. Antimicrobial resistance genes in ESBL-producing Escherichia coli isolates from animals in Greece. Antibiotics. 2021;10(4):389. [DOI:10.3390/antibiotics10040389] [PMID] []
10. Nji E, Kazibwe J, Hambridge T, Joko CA, Larbi AA, Damptey LA, et al. High prevalence of antibiotic resistance in commensal Escherichia coli from healthy human sources in community settings. Sci Rep. 2021;11(1):1-11. [DOI:10.1038/s41598-021-82693-4] []
11. Carlet J. The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control. 2012;1(1):1-7.
https://doi.org/10.1186/2047-2994-1-39 [DOI:10.1186/2047-2994-2-1] [PMID] []
12. Maharjan A, Bhetwal A, Shakya S, Satyal D, Shah S, Joshi G, et al. Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults. Infect Drug Resist. 2018;11:547-54. [DOI:10.2147/IDR.S156593] [PMID] []
13. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353(18):1945-54. [DOI:10.1056/NEJMra042823] [PMID]
14. Starrels JL, Barg FK, Metlay JP. Patterns and determinants of inappropriate antibiotic use in injection drug users. J Gen Intern Med. 2009;24(2):263-9. [DOI:10.1007/s11606-008-0859-7] [PMID] []
15. Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: A systematic review and metaanalysis. Rev Infect Dis. 2016;63(3):310-8. [DOI:10.1093/cid/ciw283] [PMID]
16. Zalavras CG, Allison DC, Miller T, Patzakis MJ, Holtom P. Bacteriology of upper extremity soft tissue abscesses in injecting drug abusers. Orthop Proc. 2009;91(Suppl 11): 313.
17. Gebeyehu E, Bantie L, Azage M. Inappropriate use of antibiotics and its associated factors among urban and rural communities of Bahir Dar city administration, northwest Ethiopia. PloS One. 2015;10(9):e0138179. [DOI:10.1371/journal.pone.0138179] [PMID] []
18. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006;119(6):S3-10. [DOI:10.1016/j.amjmed.2006.03.011] [PMID]
19. Friedman H, Pross S, Klein TW. Addictive drugs and their relationship with infectious deseases. FEMS Immunol Med Microbiol. 2006;47(3):330-42. [DOI:10.1111/j.1574-695X.2006.00097.x] [PMID]
20. Raffelsberger N, Buczek DJ, Svendsen K, Småbrekke L, Pöntinen AK, Löhr IH, et al. Community carriage of ESBL-producing Escherichia coli and Klebsiella pneumoniae: A cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates. mSphere. 2023;8(4):e00025-23. [DOI:10.1128/msphere.00025-23] [PMID] []
21. Sintondji K, Fabiyi K, Hougbenou J. Prevalence and characterization of ESBL-producing Escherichia coli in healthy pregnant women and hospital environments in Benin: An approach based on Tricycle. Front Public Health. 2023;11:1227000. [DOI:10.3389/fpubh.2023.1227000] [PMID] []
22. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, et al. Distribution of bla TEM, bla SHV, bla CTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad hospital, Tehran, Iran. Microb Drug Resist. 2010;16(1):49-53. [DOI:10.1089/mdr.2009.0096] [PMID]
23. Nathisuwan S, Burgess DS, Lewis JS. Extended‐spectrum β‐lactamases: Epidemiology, detection, and treatment. Pharmacotherapy. 2001;21(8):920-8. [DOI:10.1592/phco.21.11.920.34529] [PMID]
24. Ashayeri-Panah M, Feizabadi MM, Eftekhar F. Correlation of multi-drug resistance, integron and blaESBL gene carriage with genetic fingerprints of extended-spectrum β-lactamase producing Klebsiella pneumoniae. Jundishapur J Microbiol. 2014;7(2):e8747. [DOI:10.5812/jjm.8747] [PMID] []
25. Manandhar S, Zellweger RM, Maharjan N, Dongol S, Prajapati KG, Thwaites G, et al. A high prevalence of multidrug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of extended-spectrum beta-lactamase (ESBL) and carbapenemase-encoding genes. Ann Clin Microbiol Antimicrob. 2020;19(1):1-13. [DOI:10.1186/s12941-020-00390-y] [PMID] []
26. Mahazu S, Sato W, Ayibieke A, Prah I, Hayashi T, Suzuki T, et al. Insights and genetic features of extended-spectrum beta-lactamase producing Escherichia coli isolates from two hospitals in Ghana. Sci Rep. 2022;12(1):1-11. [DOI:10.1038/s41598-022-05869-6] [PMID] []
27. Akya A, Lorestani RC, Rostamian M, Elahi A, Baakhshii S, Aliabadi M, et al. The relationship of class I integron gene cassettes and the multidrug-resistance in extended-spectrum β-lactamase producing isolates of Escherichia coli. Arch Pediatr Infect Dis. 2019;7(3):e87961. [DOI:10.5812/pedinfect.87961]
28. Negeri AA, Mamo H, Gurung JM, Firoj Mahmud AK, Fällman M, Seyoum ET, et al. Antimicrobial resistance profiling and molecular epidemiological analysis of extended spectrum β-lactamases produced by extraintestinal invasive Escherichia coli isolates from Ethiopia: The presence of international high-risk clones ST131 and ST410 reveal. Front Microbiol. 2021;12:706846. [DOI:10.3389/fmicb.2021.706846] [PMID] []
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |